Evidence map›Paper›PMID 39138382›Full record

ArticleNature chemical biology2025

Persistent glucose consumption under antibiotic treatment protects bacterial community.

Yuzhen Zhang, Yumin Cai, Xin Jin, Qile Wu, Fan Bai, Jintao Liu

Abstract read
PubMed Publisher
In one paragraph

Article in Nature chemical biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. The Adaptations ofThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2026
    Article
  7. L-Arabinose Alters theMicroorganisms · 2025
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yuzhen Zhang *Center for Infection Biology, School of Basic Medical Sciences, Tsinghua University, Beijing, China. zhangyuzhen@tsinghua.edu.cn.ORCID 0000-0003-1112-0289
Yumin Cai *Center for Infection Biology, School of Basic Medical Sciences, Tsinghua University, Beijing, China.
Xin JinBiomedical Pioneering Innovation Center, School of Life Sciences, Peking University, Beijing, China.
Qile WuCenter for Infection Biology, School of Basic Medical Sciences, Tsinghua University, Beijing, China.
Fan BaiBiomedical Pioneering Innovation Center, School of Life Sciences, Peking University, Beijing, China.ORCID 0000-0001-6119-8936
Jintao LiuCenter for Infection Biology, School of Basic Medical Sciences, Tsinghua University, Beijing, China. jintaoliu@tsinghua.edu.cn.ORCID 0000-0002-6710-2605

Funding

National Natural Science Foundation of China (National Science Foundation of China) 32170099
6 · The paper itself

Abstract

Antibiotics typically induce major physiological changes in bacteria. However, their effect on nutrient consumption remains unclear. Here we found that Escherichia coli communities can sustain normal levels of glucose consumption under a broad range of antibiotics. The community-living resulted in a low membrane potential in the bacteria, allowing slow antibiotic accumulation on treatment and better adaptation. Through multi-omics analysis, we identified a prevalent adaptive response characterized by the upregulation of lipid synthesis, which substantially contributes to sustained glucose consumption. The consumption was maintained by the periphery region of the community, thereby restricting glucose penetration into the community interior. The resulting spatial heterogeneity in glucose availability protected the interior from antibiotic accumulation in a membrane potential-dependent manner, ensuring rapid recovery of the community postantibiotic treatment. Our findings unveiled a community-level antibiotic response through spatial regulation of metabolism and suggested new strategies for antibiotic therapies.

Indexed as

Anti-Bacterial AgentsEscherichia coliGlucoseMembrane PotentialsAnti-Bacterial AgentsGlucose

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.